Altered profile of serum <scp>microRNAs</scp> in pancreatic cancer‐associated new‐onset diabetes mellitus

Abstract

The six-serum miRNA panel may have potential as a biomarker for the accurate diagnosis and discrimination of PaC-DM from healthy controls and non-cancer new-onset T2DM.